Cureseq

CureSeq's mission is to revolutionize the field of oncology with next-generation sequencing by making it more affordable and providing faster result times through comprehensive solutions. Their products can advance your research efforts, and their services will soon be available. The turnaround time for using their products is 48 hours from extraction to generating clinically relevant mutations. CureSeq's technology was born in the Applied Genomics Laboratory of Thoracic Oncology led by Dr. Il-Jin Kim at the University of California, San Francisco.